Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting.

AKI biomarkers machine learning outcome pragmatic trial

Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
31 03 2023
Historique:
received: 09 09 2021
medline: 4 4 2023
pubmed: 14 1 2022
entrez: 13 1 2022
Statut: ppublish

Résumé

Acute kidney injury (AKI) is a growing epidemic and is independently associated with increased risk of death, chronic kidney disease (CKD) and cardiovascular events. Randomized-controlled trials (RCTs) in this domain are notoriously challenging and many clinical studies in AKI have yielded inconclusive findings. Underlying this conundrum is the inherent heterogeneity of AKI in its etiology, presentation and course. AKI is best understood as a syndrome and identification of AKI subphenotypes is needed to elucidate the disease's myriad etiologies and to tailor effective prevention and treatment strategies. Conventional RCTs are logistically cumbersome and often feature highly selected patient populations that limit external generalizability and thus alternative trial designs should be considered when appropriate. In this narrative review of recent developments in AKI trials based on the Kidney Disease Clinical Trialists (KDCT) 2020 meeting, we discuss barriers to and strategies for improved design and implementation of clinical trials for AKI patients, including predictive and prognostic enrichment techniques, the use of pragmatic trials and adaptive trials.

Identifiants

pubmed: 35022767
pii: 6505137
doi: 10.1093/ndt/gfac003
pmc: PMC10064977
doi:

Types de publication

Review Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-844

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK093770
Pays : United States
Organisme : NIDDK NIH HHS
ID : UH3 DK114866
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK060990
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL085757
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK106962
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.

Références

Lancet. 2016 May 14;387(10032):2017-25
pubmed: 27086173
Intensive Care Med. 2015 Aug;41(8):1411-23
pubmed: 26162677
Eur J Heart Fail. 2011 Nov;13(11):1224-30
pubmed: 21926073
JAMA. 2016 May 24-31;315(20):2190-9
pubmed: 27209269
N Engl J Med. 2016 Jul 14;375(2):122-33
pubmed: 27181456
Crit Care Med. 2014 Sep;42(9):2109-17
pubmed: 24810531
Ann Thorac Surg. 2018 Apr;105(4):1094-1101
pubmed: 29382510
BMJ. 2018 Nov 28;363:k4738
pubmed: 30487232
PLoS One. 2014 Nov 11;9(11):e112313
pubmed: 25386851
Lancet. 2015 May 16;385(9981):1966-74
pubmed: 25726515
Am J Kidney Dis. 2021 Oct;78(4):614-616
pubmed: 34245820
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Anesthesiology. 2020 Mar;132(3):461-475
pubmed: 31794513
J Am Soc Nephrol. 2016 Nov;27(11):3291-3297
pubmed: 27257045
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1935-1943
pubmed: 27633727
N Engl J Med. 2020 Jun 4;382(23):2238-2247
pubmed: 32492305
JAMA. 2014 Dec 3;312(21):2254-64
pubmed: 25399007
BMJ. 2021 Jan 18;372:m4786
pubmed: 33461986
N Engl J Med. 2018 Mar 1;378(9):819-828
pubmed: 29485926
Nat Rev Nephrol. 2020 Jan;16(1):20-31
pubmed: 31511662
JAMA. 2017 Oct 10;318(14):1346-1357
pubmed: 28973220
J Am Soc Nephrol. 2021 Dec 1;32(12):2994-3015
pubmed: 34556489
Nat Med. 2018 Sep;24(9):1351-1359
pubmed: 30127395
N Engl J Med. 2012 Apr 19;366(16):1489-97
pubmed: 22449296
Intensive Care Med. 2013 Jan;39(1):101-8
pubmed: 23001448
JAMA. 2018 Nov 20;320(19):1998-2009
pubmed: 30357272
NPJ Digit Med. 2020 Oct 26;3:139
pubmed: 33134556
Intensive Care Med. 2017 Nov;43(11):1551-1561
pubmed: 28110412
Nephron. 2017;137(4):297-301
pubmed: 28595193
N Engl J Med. 2018 Feb 15;378(7):603-614
pubmed: 29130810
BMJ Open. 2016 Sep 27;6(9):e012371
pubmed: 27678541
N Engl J Med. 2018 Jun 14;378(24):2263-2274
pubmed: 29742967
Anesth Analg. 2021 Aug 1;133(2):292-302
pubmed: 33684086
Am J Kidney Dis. 2020 Apr;75(4):508-512
pubmed: 32037098
BMJ. 2018 Mar 8;360:k698
pubmed: 29519932
Biostatistics. 2013 Sep;14(4):613-25
pubmed: 23525452
Clin J Am Soc Nephrol. 2018 Jun 7;13(6):949-951
pubmed: 29674341
JAMA Netw Open. 2020 Aug 3;3(8):e2012892
pubmed: 32780123
Kidney Int. 2021 Mar;99(3):498-510
pubmed: 33637194
Crit Care Med. 2019 Jul;47(7):910-917
pubmed: 30985388
Anesthesiology. 2015 Sep;123(3):515-23
pubmed: 26181335
Clin J Am Soc Nephrol. 2020 Dec 7;15(12):1838-1847
pubmed: 32317329
JAMA. 2018 Dec 11;320(22):2369-2370
pubmed: 30453322
Am J Respir Crit Care Med. 2020 Sep 15;202(6):822-829
pubmed: 32516543
Circ Heart Fail. 2011 Nov;4(6):685-91
pubmed: 21903907
N Engl J Med. 2020 Nov 19;383(21):2030-2040
pubmed: 33031652
JAMA. 2018 Oct 9;320(14):1455-1463
pubmed: 30304428
Trials. 2019 Mar 5;20(1):160
pubmed: 30836981
Kidney Int. 2019 Nov;96(5):1083-1099
pubmed: 31443997
Crit Care Med. 2019 Dec;47(12):e953-e961
pubmed: 31567524
Semin Nephrol. 2016 Jan;36(1):42-52
pubmed: 27085734
Trials. 2020 Jul 1;21(1):601
pubmed: 32611377
Ann Intensive Care. 2021 Apr 15;11(1):60
pubmed: 33856581
Am J Respir Crit Care Med. 2021 May 1;203(9):1053-1055
pubmed: 33357099
Anesthesiology. 2013 Sep;119(3):507-15
pubmed: 23835589
N Engl J Med. 2018 Mar 1;378(9):829-839
pubmed: 29485925
Clin J Am Soc Nephrol. 2012 May;7(5):844-50
pubmed: 22442182
Am J Kidney Dis. 2021 Jun;77(6):920-930.e1
pubmed: 33279558
Intensive Care Med. 2021 Aug;47(8):835-850
pubmed: 34213593
Nat Rev Nephrol. 2017 Apr;13(4):241-257
pubmed: 28239173
Nature. 2019 Aug;572(7767):116-119
pubmed: 31367026
JAMA Netw Open. 2020 Oct 1;3(10):e2019209
pubmed: 33021646
Am J Respir Crit Care Med. 2017 Mar 15;195(6):784-791
pubmed: 27635668
N Engl J Med. 2016 Aug 4;375(5):454-63
pubmed: 27518663
Am J Respir Crit Care Med. 2019 Apr 1;199(7):863-872
pubmed: 30334632

Auteurs

Daniel Lazzareschi (D)

Department of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.

Ravindra L Mehta (RL)

Department of Medicine, University of California, San Diego, San Diego, CA, USA.

Laura M Dember (LM)

Renal-Electrolyte and Hypertension Division, Department of Medicine, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Pennsylvania, PA, USA.

Juliane Bernholz (J)

AM-Pharma, Utrecht, The Netherlands.

Alparslan Turan (A)

Department of Anesthesiology, Lerner College of Medicine of Case Western University, Cleveland, OH, USA.
Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

Amit Sharma (A)

Bayer Pharmaceuticals, Cambridge, MA, USA.

Sachin Kheterpal (S)

Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.

Chirag R Parikh (CR)

Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Omar Ali (O)

Verpora Ltd, Nottingham, UK.
University of Portsmouth, UK.

Ivonne H Schulman (IH)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Abigail Ryan (A)

Division of Chronic Care Management, Centers for Medicare & Medicaid Services, Woodlawn, MD, USA.

Jean Feng (J)

Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF), San Francisco, CA, USA.

Noah Simon (N)

Department of Biostatistics, University of Washington (UW), Seattle, WA, USA.

Romain Pirracchio (R)

Department of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.

Patrick Rossignol (P)

INI-CRCT Network, Nancy, France.
University of Lorraine, Inserm 1433 CIC-P CHRU de Nancy, Inserm U1116, Nancy, France.

Matthieu Legrand (M)

Department of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
INI-CRCT Network, Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH